IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
CNLMU News
Archived Headlines
Biotech acquisition company CB Pharma Acquisition prices IPO at $10
CB Pharma Acquisition, a biotech-focused blank check company backed by Coronado Biosciences, raised $40 million by offering 4.0 million units at $10 each on Friday, as expected. At that price, CB Pharma Acquisition commands a market value of about $52 million. The company is led by Lindsay Rosenwald, the CEO of Coronado Biosciences. Coronado trades on the NASDAQ under the...read more
A blank check for biotechs: CB Pharma Acquisition files and sets terms for $40 million IPO
CB Pharma Acquisition, a biotech-focused blank check company backed by Coronado Biosciences, announced terms for its IPO on Thursday. The Burlington, MA-based company plans to raise $40 million by offering 4.0 million units for $10 each. At that price, CB Pharma Acquisition would command a market value of about $52 million. The company is led by Lindsay Rosenwald, the CEO of...read more